Melis Emanet

Melis Emanet

Auto-generated profile, based on publicly available information

Melis Emanet

Smart Bio-Interfaces, Istituto Italiano di Tecnologia, Viale Rinaldo Piaggio 34, 56025 Pontedera, Italy

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2023 in Advanced NanoBiomed Research
Verified
Journal Article
Open access
MEMelis Emanet
Melis Emanet
GCGianni Ciofani
Gianni Ciofani
Ethosomes are novel lipid‐based vesicular systems that demonstrate unique improvements in drug delivery with respect to other nanoparticles, especially for transdermal applications. Their high ethanol content strongly improves flexibility and deformability, which allows squeezing through the intercellular spaces without any drug leakage. The ethanol, moreover, contributes to increase the fluidity of the lipids of the cell membranes in dermal layers, allowing an in‐depth penetration of the nanostructures. Moreover, the high ethanol content of ethosomes allows the promotion of the encapsulation of either hydrophilic or lipophilic active agents, a feature particularly useful when it deals with natural extracts, a family of compounds characterized by a huge chemical variability. As a further advantage, being natural extracts often obtained in ethanol‐based solutions, their incorporation in ethosomes makes not necessarily expensive and time‐consuming procedures finalized at solvent removal. Following the initial exploitation of ethosomes, research focuses on the development of variants such as invasomes and transethosomes, which show improved drug encapsulation and delivery capacity. This review provides the state‐of‐the‐art on ethosomal research, with special attention on the encapsulation and delivery of natural extracts and their transdermal delivery.

26 July 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
MEMelis Emanet
Melis Emanet
MLMarie Celine Lefevre
Marie Celine Lefevre
MCMaria Cristina Ceccarelli
Maria Cristina Ceccarelli
MBMatteo Battaglini
Matteo Battaglini
ACAlessio Carmignani
Alessio Carmignani
GCGianni Ciofani
Gianni Ciofani
Polydopamine nanoparticles (PDA NPs) are proposed as an anti-cancer tool against hepatocellular carcinoma through the combination of near-infrared (NIR)-mediated hyperthermia and loading with a chemotherapeutic drug, sorafenib (SRF). Cell membranes isolated from a liver cancer cell line (HepG2) have been exploited for the coating of the nanoparticles (thus obtaining CM-SRF-PDA NPs), to promote homotypic targeting toward cancer cells. The selective targeting ability and the combined photothermal and chemotherapeutic activity of the CM-SRF-PDA NPs following NIR irradiation have been evaluated on cell cultures in static and dynamic conditions, besides three-dimensional culture models. Eventually, the therapeutic effectiveness of the proposed approach has also been tested ex ovo on HepG2 spheroid-grafted quail embryos. This comprehensive investigation, supported by proteomic analysis, showed the effectiveness of the proposed nanoplatform and strongly suggests further pre-clinical testing in the treatment of liver cancer.

5 August 2022 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
MEMelis Emanet
Melis Emanet
ÖŞÖzlem Şen
Özlem Şen
FPFrancesca Pignatelli
Francesca Pignatelli
CLChiara Lavarello
Chiara Lavarello
APAndrea Petretto
Andrea Petretto
GCGianni Ciofani
Gianni Ciofani
Reactive oxygen species (ROS) are a common hallmark of many degenerative diseases, developing in all those cases where a failure of physiological antioxidant mechanisms occurs (in particular, antioxidant enzymes and the glutathione system), or in case of exposure to an extremely high level of oxidants. In this regard, antioxidant natural extracts are promising compounds as preventive or therapeutic agents against ROS-dependent degenerations. In this study, a deep investigation of hazelnut (Corylus avellana) extract has been performed in terms of mass spectroscopy, evaluation of phenolic content, and antioxidant capacity. Then, nanostructured lipid carriers (NLCs) have been exploited for encapsulation of the hazelnut extracts in order to achieve prolonged bioactivity, increased stability, and targeting through a sustainable delivery approach. The hazelnut extract-loaded NLCs (NE_NLCs) have been deeply characterized for their stability, production yield, and encapsulation efficiency. Moreover, NE_NLCs showed optimal cytocompatibility on human dermal fibroblast (HDF) cells, as well as excellent antioxidant activity, upon pro-oxidant stimulus on HDF cells.

5 December 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
ÖŞÖzlem Şen
Özlem Şen
MEMelis Emanet
Melis Emanet
MMMartina Mazzuferi
Martina Mazzuferi
MBMartina Bartolucci
Martina Bartolucci
FCfederico Catalano
federico Catalano
GCGianni Ciofani
Gianni Ciofani
Microglial cells play a critical role in glioblastoma multiforme (GBM) progression, which is considered a highly malignant brain cancer. The activation of microglia can either promote or inhibit GBM growth depending on the stage of the tumor development and on the microenvironment conditions. The current treatments for GBM have limited efficacy; therefore, there is an urgent need to develop novel and efficient strategies for drug delivery and targeting: in this context, a promising strategy consists of using nanoplatforms. This study investigates the microglial response and the therapeutic efficacy of dual-cell membrane-coated and doxorubicin-loaded hexagonal boron nitride nanoflakes tested on human microglia and GBM cells. Obtained results show promising therapeutic effects on glioma cells and an M2 microglia polarization, which refers to a specific phenotype or activation state that is associated with anti-inflammatory and tissue repair functions, highlighted through proteomic analysis.

25 November 2022 in ACS Applied Bio Materials
Verified
Journal Article
Open access
MEMelis Emanet
Melis Emanet
MOMayu Okuda
Mayu Okuda
ÖŞÖzlem Şen
Özlem Şen
CLChiara Lavarello
Chiara Lavarello
APAndrea Petretto
Andrea Petretto
GCGianni Ciofani
Gianni Ciofani
Under healthy physiological conditions, living organisms possess a variety of antioxidant mechanisms to scavenge overproduced reactive oxygen species (ROS). However, under pathological circumstances, endogenous antioxidant systems may not be adequate to eliminate the excessive amount of oxidants, and thus, a continuous exogenous antioxidant income is required. In this regard, sumac (Rhus coriaria) extract is a good candidate for therapeutic applications, because of its high content of antioxidant polyphenolic compounds. In this work, sumac extract-loaded nanosheets (sumac-nanosheet) have been exploited for loading and controlled release of sumac extract, envisioning topical drug delivery applications. Sumac extract has been obtained through the solvent extraction method, and polymeric nanosheets have been thereafter prepared through the spin coating-assisted layer-by-layer deposition of polycaprolactone (PCL), sumac extract, and poly(d,l-lactic acid) (PDLLA). The collected data show a rich content of the sumac extract in terms of polyphenolic compounds, as well as its strong antioxidant properties. Moreover, for the first time in the literature, we demonstrated the possibility of efficiently loading such extract in polymeric nanosheets and the suitability of this nanoplatform as a reactive oxygen species scavenger in human dermal fibroblasts treated with a pro-oxidant insult.

18 June 2025 in ACS Omega
Verified
Journal Article
Open access
MEMelis Emanet
Melis Emanet
MBMatteo Battaglini
Matteo Battaglini
ACAlessio Carmignani
Alessio Carmignani
FCfederico Catalano
federico Catalano
MBMartina Bartolucci
Martina Bartolucci
GCGianni Ciofani
Gianni Ciofani
Wound healing involves a series of complex bioprocesses, including repairing skin damage, maintaining its barrier features, and preserving all other skin functions. Since the skin is the primary organ exposed to external factors, these bioprocesses can be interrupted by potential exogenous toxicants. Efforts to mitigate the effects of these toxicants can help accelerate the healing process, facilitating complete wound recovery. In this context, sumac (Rhus coriaria) extract, rich in polyphenolics with antioxidant and anti-inflammatory properties, can be exploited to overcome oxidant and inflammation-dependent burdens. Ethosomes, lipid-based intradermal delivery vehicles, have been selected for the delivery of sumac extract, as they enhance penetration through the skin layers. Considering their remarkable flexibility and deformability, ethosomes can minimize drug leakage even under harmful penetration conditions. Given the diverse bioactive content of sumac extract, ethosomes have been considered ideal for delivering both hydrophilic and lipophilic active compounds. Sumac extract (SuExt)-loaded ethosomes (SuExt-ethosomes) were therefore produced and characterized. These nanocarriers demonstrated significant cellular internalization and cytocompatibility in human dermal fibroblasts (HDFs), along with excellent antioxidant and anti-inflammatory activity. A comprehensive investigation, supported by proteomic analysis, revealed that SuExt-ethosomes present promising wound healing potential, supporting future investigations in preclinical models.